[Form 4] AXON ENTERPRISE, INC. Insider Trading Activity

Rhea-AI Filing Summary

Axon Enterprise, Inc. (AXON) reported an insider equity award for its Chief Revenue Officer. On 11/13/2025, 15,810 shares of common stock were acquired at a price of $0, increasing the officer’s directly held stake to 60,278 shares. These shares relate to performance-based restricted stock units (XSUs) originally granted on April 1, 2024, for which the performance conditions for the third tranche were certified as achieved on that date.

The certified tranche will vest on October 1, 2026, subject to continued employment through that date. After vesting, the delivered shares are subject to a minimum holding period until the earlier of December 31, 2030 or the vesting of a subsequent XSU tranche, other than any shares withheld or sold to cover taxes.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brooks Cameron

(Last) (First) (Middle)

17800 NORTH 85TH STREET

(Street)

SCOTTSDALE AZ 85255

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF REVENUE OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/13/2025		A(1)		15,810	A	$0	60,278	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transaction consists of performance-based restricted stock units (collectively, "XSUs") granted on April 1, 2024 pursuant to the Axon Enterprise, Inc. 2024 eXponential Stock Plan, for which the performance conditions for the third tranche of XSUs (the "Tranche") were certified by the issuer's Compensation Committee of the Board of Directors on November 13, 2025 as having been met. The Tranche will vest on October 1, 2026, subject to continued employment through such date. Following the vesting, the shares deliverable for the Tranche are subject to a minimum holding period until the earlier of (i) December 31, 2030 and (ii) the date on which a subsequent tranche of XSUs vests, excluding shares withheld or sold to cover applicable taxes.

Remarks:

	/s/ Cameron Brooks by Isaiah Fields, Attorney-in-Fact	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Axon (AXON) report in this Form 4?

The filing reports that Axon’s Chief Revenue Officer acquired 15,810 shares of common stock on 11/13/2025 at a price of $0, reflecting the settlement terms of performance-based restricted stock units.

What are the performance-based RSUs reported for Axon (AXON)?

The transaction involves performance-based restricted stock units (XSUs) granted on April 1, 2024 under the Axon Enterprise, Inc. 2024 eXponential Stock Plan. The filing states that performance conditions for the third tranche were certified as met on November 13, 2025.

When will the reported Axon (AXON) RSU tranche vest and be subject to holding requirements?

The filing states that the third tranche of XSUs will vest on October 1, 2026, subject to continued employment through that date. After vesting, the delivered shares are subject to a minimum holding period until the earlier of December 31, 2030 or the vesting of a subsequent tranche, excluding shares withheld or sold for taxes.

How many Axon (AXON) shares does the reporting person own after this transaction?

Following the reported transaction, the officer beneficially owns 60,278 shares of Axon common stock, held with direct ownership according to the filing.

What role does the reporting person hold at Axon (AXON)?

The reporting person is identified as an officer of Axon Enterprise, Inc., serving as the company’s Chief Revenue Officer.